IMUX (STOCKS)
Immunic, Inc. Common Stock
$13.858500
-0.001500 (-0.01%)
Prev close: $13.860000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Erik Lundgren
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $191.45M
- Employees
- 90
- P/E (TTM)
- -2.32
- P/B (TTM)
- 1.25
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.08 | $-0.93 | -0.1492 | -16.03% |
|
Dec 2025 (Q4)
|
$-0.70 | $-0.96 | +0.2601 | +27.09% |
|
Sep 2025 (Q3)
|
$-1.30 | $-1.71 | +0.4085 | +23.91% |
|
Jun 2025 (Q2)
|
$-2.00 | $-1.68 | -0.3170 | -18.84% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $5.35M |
| Operating Expenses | $109.64M |
| Depreciation and Amortization | $158.00K |
| Research and Development | $86.08M |
| Other Operating Expenses | $23.40M |
| Operating Income/Loss | -$109.64M |
| Income/Loss From Continuing Operations After Tax | -$104.29M |
| Income/Loss From Continuing Operations Before Tax | -$104.29M |
| Net Income/Loss | -$104.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$104.29M |
| Net Income/Loss Available To Common Stockholders, Basic | -$104.29M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $595.00K |
| Basic Earnings Per Share | -$1.48 |
| Diluted Earnings Per Share | -$1.48 |
| Basic Average Shares | 369,085,831 |
| Diluted Average Shares | 369,085,831 |
| Common Stock Dividends | $0.00 |
| Assets | $189.74M |
| Current Assets | $188.76M |
| Noncurrent Assets | $983.00K |
| Fixed Assets | $566.00K |
| Other Non-current Assets | $417.00K |
| Liabilities | $38.51M |
| Current Liabilities | $38.36M |
| Accounts Payable | $11.01M |
| Other Current Liabilities | $27.35M |
| Noncurrent Liabilities | $146.00K |
| Equity | $151.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $151.23M |
| Liabilities And Equity | $189.74M |
| Net Cash Flow From Operating Activities | -$81.33M |
| Net Cash Flow From Operating Activities, Continuing | -$81.33M |
| Net Cash Flow From Investing Activities | -$116.00K |
| Net Cash Flow From Investing Activities, Continuing | -$116.00K |
| Net Cash Flow From Financing Activities | $232.86M |
| Net Cash Flow From Financing Activities, Continuing | $232.40M |
| Exchange Gains/Losses | -$447.00K |
| Net Cash Flow | $151.42M |
| Net Cash Flow, Continuing | $151.87M |
| Comprehensive Income/Loss | -$103.76M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$105.15M |
| Other Comprehensive Income/Loss | -$76.94M |